Could Biomarkers of Bone, Cartilage or Synovium Turnover Be Used for Relapse Prediction in Rheumatoid Arthritis Patients?
Objective. The aim of this review is to clarify the usefulness of bone, cartilage, and synovial biomarker in the management of rheumatoid arthritis (RA) therapy in remission. Synovial Biomarkers. High MMP-3 levels are associated with joint progression in RA patients, but there is no data about their...
Saved in:
Main Authors: | Delphine Dénarié (Author), Elodie Constant (Author), Thierry Thomas (Author), Hubert Marotte (Author) |
---|---|
Format: | Book |
Published: |
Hindawi Limited,
2014-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Methotrexate Reduced TNF Bioactivity in Rheumatoid Arthritis Patients Treated with Infliximab
by: Delphine Dénarié, et al.
Published: (2017) -
Control of articular synovitis for bone and cartilage regeneration in rheumatoid arthritis
by: Hiromu Ito, et al.
Published: (2018) -
Whole-Genome Expression Analysis and Signal Pathway Screening of Synovium-Derived Mesenchymal Stromal Cells in Rheumatoid Arthritis
by: Jingyi Hou, et al.
Published: (2016) -
Comparative Expression Analyses of Pro- versus Anti-Inflammatory Mediators within Synovium of Patients with Joint Trauma, Osteoarthritis, and Rheumatoid Arthritis
by: Mohammed A. Al-Madol, et al.
Published: (2017) -
Biomarkers in Rheumatoid Arthritis
by: Vincent Goëb, et al.
Published: (2014)